Neural progenitor cell (NPC) transplantation is a promising strategy for the treatment of spinal cord injury (SCI). In this study, we show that injury-induced Notch activation in the spinal cord microenvironment biases the fate of transplanted NPCs toward astrocytes in rodents. In a screen for potential clinically relevant factors to modulate Notch signaling, we identified glial cell-derived neurotrophic factor (GDNF). GDNF attenuates Notch signaling by mediating delta-like 1 homolog (DLK1) expression, which is independent of GDNF's effect on cell survival. When transplanted into a rodent model of cervical SCI, GDNF-expressing human-induced pluripotent stem cell-derived NPCs (hiPSC-NPCs) demonstrated higher differentiation toward a neuronal fate compared to control cells. In addition, expression of GDNF promoted endogenous tissue sparing and enhanced electrical integration of transplanted cells, which collectively resulted in improved neurobehavioral recovery. CRISPR-induced knockouts of the DLK1 gene in GDNF-expressing hiPSC-NPCs attenuated the effect on functional recovery, demonstrating that this effect is partially mediated through DLK1 expression. These results represent a mechanistically driven optimization of hiPSC-NPC therapy to redirect transplanted cells toward a neuronal fate and enhance their integration.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury.Exp Neurobiol. 2019 Dec 31;28(6):679-696. doi: 10.5607/en.2019.28.6.679. Exp Neurobiol. 2019. PMID: 31902156 Free PMC article.
Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord.J Neurosci. 2010 Feb 3;30(5):1657-76. doi: 10.1523/JNEUROSCI.3111-09.2010. J Neurosci. 2010. PMID: 20130176 Free PMC article.
Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury.PLoS One. 2012;7(5):e37589. doi: 10.1371/journal.pone.0037589. Epub 2012 May 22. PLoS One. 2012. PMID: 22629425 Free PMC article.
Applications of induced pluripotent stem cell technologies in spinal cord injury.J Neurochem. 2017 Jun;141(6):848-860. doi: 10.1111/jnc.13986. Epub 2017 Apr 5. J Neurochem. 2017. PMID: 28199003 Review.
Stem cell-based cell therapy for spinal cord injury.Cell Transplant. 2007;16(4):355-64. doi: 10.3727/000000007783464885. Cell Transplant. 2007. PMID: 17658126 Review.
Cited by 1 article
Treatment of rats with spinal cord injury using human bone marrow-derived stromal cells prepared by negative selection.J Biomed Sci. 2020 Feb 18;27(1):35. doi: 10.1186/s12929-020-00629-y. J Biomed Sci. 2020. PMID: 32066435 Free PMC article.